A combination of caffeine, arginine, soy isoflavones, and L-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo

Journal of Nutrition

Volumn 137, Issue 10, 2007, Pages 2252-2257

  Murosaki, Shinji ^a   Tae, Ryong Lee ^b   Muroyama, Koutarou ^a   Eui, Seok Shin ^b   Si, Young Cho ^b   Yamamoto, Yoshihiro ^a   Sang, Jun Lee ^b  

^a HOUSE WELLNESS FOODS CORPORATION   (Japan)

^b AmorePacific Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ARGININE; CAFFEINE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; ISOFLAVONE DERIVATIVE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CELL STRAIN HEPG2; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID OXIDATION; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OBESITY; SOYBEAN;

MUS;

EID: 34948893001     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.10.2252     Document Type: Article

References (33)

1. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-91.
3. Mannino DM, Mott J, Ferdinands JM, Camargo CA, Friedman M, Greves HM, Redd SC. Boys with high body masses have an increased risk of developing asthma: findings from the National Longitudinal Survey of Youth (NLSY). Int J Obes (Lond). 2006;30:6-13.
4. Dodd SL, Herb RA, Powers SK. Caffeine and exercise performance. An update. Sports Med. 1993;15:14-23.
5. Kalkhoff RK, Gossain VV, Matute ML. Plasma glucagon in obesity. Response to arginine, glucose and protein administration. N Engl J Med. 1973;289:465-7.
6. Muroyama K, Murosaki S, Yamamoto Y, Odaka H, Chung HC, Miyoshi M. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice. J Nutr Sci Vitaminol (Tokyo). 2003;49:56-63.
7. Muroyama K, Murosaki S, Yamamoto Y, Ishijima A, Toh Y. Effects of intake of a mixture of thiamin, arginine, caffeine, and citric acid on adiposity in healthy subjects with high percent body fat. Biosci Biotechnol Biochem. 2003;67:2325-33.
8. Thupari JN, Landree LE, Ronnett GV, Kuhajda FP. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci USA. 2002;99:9498-502.
9. Shin ES, Cho SY, Lee EH, Lee SJ, Chang IS, Lee TR. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. Eur J Nutr. 2006;45:159-64.
10. Kim S, Shin HJ, Kim SY, Kim JH, Lee YS, Kim DH, Lee MO. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα. Mol Cell Endocrinol. 2004;220:51-8.
11. Shin ES, Lee HH, Cho SY, Park HW, Lee SJ, Lee TR. Genistein downregulates SREBP-1 regulated gene expressions through the inhibition of the site-1 protease expression in HepG2 cells. J Nutr. 2007;1127-31.
12. Park HW, Yang MS, Lee JH, Shin ES, Kim Y, Chun JY, Lee TR, Lee SJ. Long term feeding with soy isoflavone and L-carnitine synergistically suppresses body weight gain and adiposity in high-fat diet induced obese mice. Nutr Sci. 2006;9:179-89.
13. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res. 2006;53:482-91.
14. Kuhajda FP, Landree LE, Ronnett GV. The connections between C75 and obesity drug-target pathways. Trends Pharmacol Sci. 2005;26:541-4.
15. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
16. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, et al. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. J Clin Endocrinol Metab. 2001;86:1930-5.
17. Statnick MA, Beaverse LS, Conner LJ, Corominola H, Johason D, Hammond CD, Rafaeloff-Phasil R, Seng T, Suter TM, et al. Decrease expression of apM-1 I omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res. 2000;1:81-8.
18. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickon MRS, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage production of 30 kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001;98:2005-10.
19. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947-53.
20. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-6.
21. Iritani N, Nagashima K, Fukuda H, Katsurada A, Tanaka T. Effects of dietary proteins on lipogenic enzymes in rat liver. J Nutr. 1986;116:190-7.
22. Nurjhan N, Kennedy F, Consoli A, Martin C, Miles J, Gerich J. Quantification of the glycolytic origin of plasma glycerol: implications for the use of the rate of appearance of plasma glycerol as an index of lipolysis in vivo. Metabolism. 1988;37:386-9.
23. 2-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J Clin Endocrinol Metab. 2001;86:2191-9.
24. Horowitz JF, Klein S. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am J Physiol Endocrinol Metab. 2000;278:E1144-52.
25. Furuyashiki T, Nagayasu H, Aoki Y, Bessho H, Hashimoto T, Kanazawa K, Ashida H. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem. 2004;68:2353-9.
26. Harper AE. Amino acid balance and imbalance. J Nutr. 1959;68:405-18.
27. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
28. van Baak MA. Exercise training and substrate utilisation in obesity. Int J Obes Relat Metab Disord. 1999;23 Suppl 3:S11-7.
29. Mittendorfer B, Fields DA, Klein S. Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am J Physiol Endocrinol Metab. 2004;286:E354-62.
30. 2-adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation. Int J Obes. 2007;31:813-9. Epub 2006 Nov 28.
31. Koutsari C, Jensen MD. Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res. 2006;47:1643-50.
32. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest. 1999;104:1087-96.
33. McCarty MF. An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic-relevance to high-carbohydrate diets. Med Hypotheses. 2004;63:1065-73.